🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Background: In the last several years, commercial pharmacogenetic (PGx) tes...
Status
Unknown
Location
Cpl Michael J Crescenz VAMC
Start Date
2020-06-02
Trial ID
NCT04958824
Treatments Being Tested
RATIONALE: Studying samples of blood from patients with cancer in the labor...
Status
Completed
Location
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
Start Date
2008-06-18
Trial ID
NCT00764322
Depression is common among elderly with an estimated prevalence of 5%. Due ...
Status
Completed
Location
GGZ WNB
Start Date
2013-02
Trial ID
NCT01778907
Treatments Being Tested
This study aims to evaluate the efficacy of genotype-informed Bayesian dosi...
Status
Recruiting
Location
Royal Children's Hospital
Start Date
2024-08-05
Trial ID
NCT06529536
Treatments Being Tested
The advent of anti-retroviral therapy (ART) for people living with HIV/AIDS...
Status
Active Not Recruiting
Location
Northwestern University
Start Date
2020-02-17
Trial ID
NCT04176172
Pharmacogenomics (PGx) Applied to Chronic pain Treatment in primary care (P...
Status
Unknown
Location
MedStar Good Samaritan Hospital
Start Date
2020-12-02
Trial ID
NCT04685304
Treatments Being Tested
The purpose of this study is to assess the clinical impact of reducing trea...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-08-15
Trial ID
NCT06210321
Treatments Being Tested
RATIONALE: AR-42 may stop the growth of cancer cells by blocking some of th...
Status
Completed
Location
The Ohio State University James Cancer Hospital
Start Date
2010-05-04
Trial ID
NCT01129193
Treatments Being Tested
This randomized phase III trial studies sorafenib tosylate and doxorubicin ...
Status
Completed
Location
University of Alabama at Birmingham Cancer Center
Start Date
2010-02-15
Trial ID
NCT01015833
This randomized phase III trial studies ibrutinib to see how well it works ...
Status
Active Not Recruiting
Location
Anchorage Associates in Radiation Medicine
Start Date
2016-10-12
Trial ID
NCT02443077